Jsmc-10361

EVALUATION OF RED BLOOD CELL INDICES IN TYPE 2 DIABETES MELLITUS IN SULAYMANIYAH CITY, KURDISTAN REGION, IRAQ

Hisham Arif Alrawi a

a College of Medicine, University of Sulaimani, Kurdistan Region, Iraq 

Submitted: 25/8/2021; Accepted: 20/2/2022; Published: 21/6/2022

DOI Link: https://doi.org/10.17656/jsmc.10361 

ABSTRACT 

Background 

Type 2 diabetes mellitus (T2DM) accounts for more than 90% of all diagnosed cases of diabetes. Earlier reports described an independent association of haematological indices, such as red blood cells (RBCs), haemoglobin (Hb), hematocrit (Hct), mean corpuscular haemoglobin (MCV), platelet count (Plt), and white blood cell count (WBC) with the risk of occurrence of T2DM.

Objectives 

To evaluate the relationship between T2DM and red cell indices.

Patients and Methods

The current cross-sectional study recruited 400 patients with T2DM who were referred to the Diabetic Center in Sulaimani city, Northern Iraq, from November 2018 to March 2019 and 200 healthy blood donors who donated from March to April 2019 to the Sulaimani Blood Bank Center. The required data were collected from both groups, and relevant haematological tests and biochemical analyses were performed. 

Results

Anemia was found in 8% of the patients giving higher rates among the females. Normocytic anaemia was observed in (82.8%) of the patients. Half of the patients had a high level of RBC counts, which correlates significantly with high HbA1c (p=0.005). The prevalence of pre-diabetic and diabetes was 15.5% among healthy blood donors. Patients with T2DM and donation experience showed lower HbA1c levels than those without blood donation (p<0.05). 

Conclusion

Normocytic anaemia is the most common type in patients with T2DM. Patients with a high level of RBC count might be worth screening for T2DM. A high frequency of pre-diabetic and diabetic among asymptomatic healthy blood donors was observed.

KEYWORDS

Type 2 diabetes mellitus, Red blood cell indices, Red blood cell count, Glycosylated haemoglobin.

References 

1. Antwi-Balfour S, Hammond S, Adjei JK, Kyeremeh R, Martin-Odoom A, Ekem I. A case-control study of the prevalence of anaemia among patients with type 2 diabetes. J Med Case Rep. 2016; 10 (1): 110. 

2. Cho YI, M.P Mooney, DJ Cho. Hemorheological disorders in diabetes mellitus. J diabetes sci technol. 2008; 2(6):1130-1138.

3. Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Perticone M, Sciacqua A, et al. Elevated 1-h post-challenge plasma glucose levels in subjects with standard glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity. Acta Diabetol. 2017; 54(8): 775-784. 

4. Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Succurro E, Sciacqua A, et al. Hemorheological alterations in adults with prediabetes identified by haemoglobin A1c levels. Nutr Metab Cardiovasc Dis. 2017; 27(7): 601-608. 

5. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN; DCCT/EDIC Research Group. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited. Diabetes. 2008; 57(4): 995-1001. 

6. Fadini GP, Morin M, Facco M, Bonamico S, Baesso I, Grego F, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005; 45(9): 1449-1457. 

7. Wang ZS, Song ZC, Bai JH, Li F, Wu T, Qi J, et al. Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus. Vasc Health Risk Manag. 2013; 9: 237-43. 

8. Milosevic D, Panin VL. Relationship between Hematological Parameters and Glycemic Control in Type 2 Diabetes Mellitus Patients. J Med Biochem. 2019; 38(2): 164-171. 

9. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002; 51(2): 455-461. 

10. Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, et al. White blood cell count is associated with macro-and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care. 2004; 27(1): 216-222. 

11. Deng Y, Papageorgiou DP, Li X, Perakakis N, Mantzoros CS, Dao M, et al. Quantifying Fibrinogen-Dependent Aggregation of Red Blood Cells in Type 2 Diabetes Mellitus. Biophys J. 2020; 119(5): 900-912. 

12. Nguyen QM, Xu J-H, Chen W, Srinivasan SR, Berenson GS. Correlates of age onset of type 2 diabetes among relatively young black and white adults in a community. Diabetes Care. 2012; 35:1341-1346.

13. Harrigan N. Risk Factors for Type 2 Diabetes. US Pharm. 2007; 32(10): 61-63.

14. Akter S, Rahman MM, Krull Abe S, Sultana P. Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey. Bulletin of the World Health Organization 2014; 92: 204-213A.

15. Florkowski C. HbA1c as a Diagnostic Test for Diabetes Mellitus - Reviewing the Evidence. ClinBiochem Rev. 2013; 34(2): 75-83.

16. Bonakdaran S, Gharebaghi M, Vahedian M. Prevalence of anaemia in type-2 diabetes and renal involvement. Saudi J Kidney Dis Transpl. 2011; 22: 286-290.

17. Yang J, Yan PJ, Wan Q, Li H. Association between haemoglobin levels and diabetic peripheral neuropathy in patients with type 2 diabetes: a cross-sectional study using electronic health records J. Diabetes Res. 2017; p. 2835981.

18. Idris I, Tohid H, Muhammad NA, A Rashid MR, Mohd Ahad A, Ali N, et al. Anaemia among primary care patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD): a multicentred cross-sectional study. BMJ Open. 2018; 8(12): e025125. 

19. Harita N, Hayashi T, Sato KK, Nakamura Y, Yoneda T, Endo G, et al. Lower serum creatinine is a new risk factor of type 2 diabetes: the Kansai healthcare study. Diabetes Care. 2009; 32(3): 424-426. 

20. Jurkovitz CT, Abramson JL, Vaccarino LV, Weintraub WS, McClellan WM. Association of high serum creatinine and anaemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol. 2003; 14(11): 2919-2925. 

21. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001; 345(11): 790-797. 

22. Malena M, Prnjavorac B, Bego T, Dujic T, Semiz S, Skrbo S, et al. Effect of Cigarette Smoking on Haematological Parameters in Healthy Population. Med. Arch. 2017; 71: 132-136. 

23. WHO Blood Safety Indicators, 2007. Geneva: World Health Organization; 2009.

24. Li Q, Li L, Li Y. Enhanced RBC aggregation in type 2 diabetes patients. Journal of Clinical Laboratory Analysis. 2015; 29: 387–389.

25. Jaman S, Rahman S, Rubaiya SRR, Mahato J, Miah MM, Ayshasiddeka M, et al. Diabetes and red blood cell parameters. Ann Clin Endocrinol Metabol. 2018; 2:1-9.

26. Sheikhpour R, Sadeghian F, Rajabi S. Correlation between glycated haemoglobin, serum glucose and serum lipid levels in type 2 diabetes. Iranian Journal of Diabetes and Obesity. 2013; 5(1): 12-15.

27. Tamariz LJ, Young JH, Pankow JS, Yeh HC, Schmidt MI, Astor B, et al. Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol. 2008; 168(10): 1153-1160. 

28. Milosevic D, Panin VL. Relationship between Hematological Parameters and Glycemic Control in Type 2 Diabetes Mellitus Patients. J Med Biochem. 2019; 38(2):164-171.

29. Bigna JJ, Nansseu JR, Katte JC, Noubiap JJ. Prevalence of prediabetes and diabetes mellitus among adults residing in Cameroon: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2018; 137: 109-118. 

30. Mirahmadizadeh A, Fathalipour M, Mokhtari AM, Zeighami S, Hassanipour S, Heiran A. et al. The prevalence of undiagnosed type 2 diabetes and prediabetes in Eastern Mediterranean Region (EMRO): A systematic review and meta-analysis. Diabetes Res Clin Pract. 2020; 160: 107931. 

31. Huang Z, Liu Y, Mao Y, Chen W, Xiao Z, Yu Y. Relationship between glycated haemoglobin concentration and erythrocyte survival in type 2 diabetes mellitus determined by a modified carbon monoxide breath test. J Breath Res. J Breath Res. 2017; 12(2): 026004. 

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.